• Basel Medical Group issued 6,000,000 new Ordinary Shares following the exercise of 6,000,000 Common Warrants.
• Holders used the zero cash exercise option, generating no new proceeds.
• The warrants originated from an offering of 6,000,000 Units, each comprising one Ordinary Share and one Common Warrant, closed October 9, 2026.
• Total Ordinary Shares issued and outstanding stood at 13,582,111 as of October 29, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-049165), on October 29, 2026, and is solely responsible for the information contained therein.